Myriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,896,899 | |||||
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.57 +0.03 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $45.34 | |||
| Open | $5.60 | 52 Week Low | $15.92 | |||
| Day High | $5.74 | P/E | 2.39 | |||
| Day Low | $5.45 | EPS | $2.33 | |||
| Volume | 4,951,510 | |||||
